Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease

Nucleic Acid–Based Therapies for Atherosclerosis

(2020) Petri Mäkinen et al.   Current Atherosclerosis Reports

Contribution of remnant cholesterol to cardiovascular risk

(2020) Anne Langsted et al.   JOURNAL OF INTERNAL MEDICINE

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

(2020) Edward K. Duran et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study

(2019) Nam Hoon Kim et al.   BMJ-British Medical Journal

Clinical review on triglycerides

(2019) Ulrich Laufs et al.   EUROPEAN HEART JOURNAL

Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease

(2019) Mohamed B Elshazly et al.   European Journal of Preventive Cardiology

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial

(2018) Antonio J. Vallejo-Vaz et al.   CIRCULATION

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

(2018) Michel R. Langlois et al.   CLINICAL CHEMISTRY

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease

(2018) Anum Saeed et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts

(2018) Ramón Estruch et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk

(2017) Anette Varbo et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Non-HDL Cholesterol and TriglyceridesHighlights

(2016) Rishi Puri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease

(2016) A.-M. K. Jepsen et al.   CLINICAL CHEMISTRY

New insights into the pathophysiology of dyslipidemia in type 2 diabetes

(2015) Marja-Riitta Taskinen et al.   ATHEROSCLEROSIS

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

(2015) A. Varbo et al.   CLINICAL CHEMISTRY

Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins

(2015) Gregory G. Schwartz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Definitions and potential health benefits of the Mediterranean diet: views from experts around the world

(2014) Antonia Trichopoulou et al.   BMC Medicine

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study

(2014) M. Thomsen et al.   CLINICAL CHEMISTRY

Mendelian randomization of blood lipids for coronary heart disease

(2014) Michael V. Holmes et al.   EUROPEAN HEART JOURNAL

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway

(2014) Grace M Egeland et al.   European Journal of Preventive Cardiology

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

(2013) Anette Varbo et al.   CIRCULATION

Common variants associated with plasma triglycerides and risk for coronary artery disease

(2013) Ron Do et al.   NATURE GENETICS

Cross-Sectional Assessment of Nut Consumption and Obesity, Metabolic Syndrome and Other Cardiometabolic Risk Factors: The PREDIMED Study

(2013) Núria Ibarrola-Jurado et al.   PLoS One

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction

(2012) Anders Berg Jørgensen et al.   EUROPEAN HEART JOURNAL

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Triglycerides and Heart Disease

(2011) Ira J. Goldberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis

(2011) Meng Lee et al.   ATHEROSCLEROSIS

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain

(2010) Joan D. Fernández-Ballart et al.   BRITISH JOURNAL OF NUTRITION

Cohort Profile: Design and methods of the PREDIMED study

(2010) M. A. Martinez-Gonzalez et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

(2010)   LANCET

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

(2010) Min Jun et al.   LANCET

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention

(2010) Kiran Musunuru   LIPIDS

Lipoprotein Management in Patients With Cardiometabolic Risk

(2008) John D. Brunzell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY